Claris Lifesciences

Claris Lifesciences is an Indian sterile injectables pharmaceutical company with a market presence across 100 countries worldwide. We manufacture and market products across multiple delivery systems, markets, and therapeutic segments. A significant majority of these products are generic drugs that are capable of being directly injected into the human body; our products are predominantly used in the treatment of critical illnesses. Our customer base primarily includes government and private hospitals, aid agencies, and nursing homes.

Our products range across various therapeutic segments, including anesthesia, anti-infectives, renal care, and enteral nutrition. We have the capability to manufacture these injectables in various delivery systems, such as glass: bottles, vials & ampoules; and non-PVC & PVC bags.

We have three manufacturing facilities at a campus located in Ahmedabad, India. Two of these facilities have been approved by certain foreign regulatory authorities, which include the USFDA, MHRA (UK), TGA (Australia), NAM (Finland), GCC FDCA (Gulf Co-operation Council including Saudi Arabia, UAE, and other countries in the Middle East), ANVISA (Brasil) and INVIMA (Colombia). Our manufacturing capabilities have received several awards from prestigious institutions like IDMA (Indian Drug Manufacturers' Association) and Frost & Sullivan.

Our capabilities and experience span across all business verticals in the generic injectables industry. We have a trained workforce across business functions, such as product development, regulatory affairs for obtaining product registrations, manufacturing, and sales & marketing